Phibro Animal Health (PAHC) Shares Outstanding (Weighted Average) (2013 - 2026)

Phibro Animal Health (PAHC) recorded quarterly Shares Outstanding (Weighted Average) of $40.6 million in Q1 2026, little changed quarter-over-quarter from $40.5 million in Q4 2025, and little changed on a YoY basis from $40.5 million in Q1 2025.

Phibro Animal Health (PAHC) Shares Outstanding (Weighted Average) (2013 - 2026) Analysis & Trends

Phibro Animal Health's Shares Outstanding (Weighted Average) history runs 14 years deep, the most recent figure standing at $40.6 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Weighted Average) changed 0.1% year-over-year to $40.6 million; the TTM figure through Mar 2026 stood at $40.6 million (changed 0.1% YoY), while the FY2025 annual figure was $40.5 million, changed 0.03% from the prior year.
  • Shares Outstanding (Weighted Average) was $40.6 million for Q1 2026 at Phibro Animal Health, roughly flat from $40.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $40.6 million in Q1 2026 to a low of $40.5 million in Q1 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $40.5 million across 5 years, with a median of $40.5 million in 2022.
  • The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) changed 0.0% in 2022, then gained 0.1% in 2026.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $40.5 million in 2022, then changed by 0.0% to $40.5 million in 2023, then changed by 0.0% to $40.5 million in 2024, then climbed by 0.07% to $40.5 million in 2025, then rose by 0.04% to $40.6 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $40.6 million (Q1 2026), $40.5 million (Q4 2025), and $40.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn 1.16 Bn
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 43.50 Mn
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn 100.50 Mn
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn 5.11 Bn
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn 166.20 Mn
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn 64.74 Mn
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn 88.01 Mn
10 Phibro Animal Health 1.29 Bn 1.22 Bn 125.68 Mn 40.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 40.55 Mn
Dec 31, 2025 40.53 Mn
Sep 30, 2025 40.53 Mn
Jun 30, 2025 40.52 Mn
Mar 31, 2025 40.51 Mn
Dec 31, 2024 40.50 Mn
Sep 30, 2024 40.50 Mn
Jun 30, 2024 40.50 Mn
Mar 31, 2024 40.50 Mn
Dec 31, 2023 40.50 Mn
Sep 30, 2023 40.50 Mn
Jun 30, 2023 40.50 Mn
Mar 31, 2023 40.50 Mn
Dec 31, 2022 40.50 Mn
Sep 30, 2022 40.50 Mn
Jun 30, 2022 40.50 Mn
Mar 31, 2022 40.50 Mn
Dec 31, 2021 40.50 Mn
Sep 30, 2021 40.50 Mn
Jun 30, 2021 40.47 Mn